New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2014
16:57 EDTSTJSt. Jude Medical: Results from quadripolar system study show cost savings
St. Jude Medical announced that data presented during Heart Rhythm 2014, the Heart Rhythm Society’s Annual Scientific Sessions, found that the use of quadripolar leads reduced the number of hospitalizations by 53% when compared to the non-quadripolar group. This hospitalization rate reduction translated into a statistically significant 62% reduction in overall costs for both health care systems and patients. The Hospitalization Rates and Associated Cost Analysis of Quadripolar versus Bipolar CRT-D: a comparative analysis of a single-center prospective Italian registry presentation includes data that demonstrated hospitalization rates for the quadripolar group were lower than the non-quadripolar group and patients with the St. Jude Medical Quartet Quadripolar LV lead and had a 98% probability of having lower costs than patients with non-quadripolar leads. The study showed that use of the quadripolar left ventricular lead was associated with significantly reduced hospitalizations specific to the two types of hospitalizations studied: heart failure and LV lead surgical revision.
News For STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2015
16:34 EDTSTJSt. Jude Medical announces FDA approval of FlexAbility Ablation Catheter
Subscribe for More Information
15:35 EDTSTJNotable companies reporting before tomorrow's open
Subscribe for More Information
January 26, 2015
07:17 EDTSTJSociety of Thoracic Surgeons to hold annual meeting
51st Annual Meeting of STS is being held in San Diego, California on January 24-28.
January 14, 2015
09:03 EDTSTJSt. Jude Medical sees Q4 adjusted EPS within $1.02-$1.04 guidance range
Subscribe for More Information
09:02 EDTSTJSt. Jude Medical sees Q4 net sales approximately $1.439B, consensus $1.44B
Subscribe for More Information
09:01 EDTSTJSt. Jude Medical authorizes $500M share repurchase program
The company announced that its board of directors has authorized the repurchase of up to $500M of St. Jude Medical common stock. The repurchases will occur at such times and at such prices as the management of the company determines and may be effected through transactions in the open market, in privately negotiated transactions or otherwise. Any shares acquired in the $500M repurchase program will be available for general corporate purposes, including offsetting dilution associated with stock option and other equity-based employee benefit plans. The company had approximately 287 million shares of common stock outstanding as of Jan. 13, 2015.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use